Concepedia

Economic evaluation of four follow-up strategies after curative treatment for breast cancer: Results of an RCT

Merel Kimman, Carmen D. Dirksen, Adri C. Voogd, P. R. J. Falger, B. Gijsen, Manfred Thüring, Antoine F. Lenssen, F. van der Ent, J. Verkeyn, C. Haekens,

European Journal of Cancer · 2011 · 64 citations · 26 references

Concepts

PharmacyOncologyPharmacoeconomicsBreast OncologyCost-effectiveness AnalysisCost-utility AnalysisBreast Cancer RadiotherapyBreast-conserving TherapyModel-based Economic EvaluationOutcome ValuationTime Horizon SelectionBias In Economic EvaluationCurative InterventionCurative TherapyEconomic Evaluation AppraisalEconomic Performance EvaluationFollow-up Schedules

References

26

Modeling Valuations for EuroQol Health States

Paul Dolan · Medical Care · 1997 · 4.6K citations

Pharmacy, Health Policy, Health Assessment +16

The friction cost method for measuring indirect costs of disease

Marc Koopmanschap, Frans Rutten, B. Martin van Ineveld et al. · Journal of Health Economics · 1995 · 1.1K citations

Pharmacy, Economics, Pharmacoeconomics +14

Representing uncertainty: the role of cost‐effectiveness acceptability curves

Elisabeth Fenwick, Karl Claxton, Mark Sculpher · Health Economics · 2001 · 1.1K citations

Pharmacy, Pharmacoeconomics, Decision Analysis +14

Estimating mean QALYs in trial‐based cost‐effectiveness analysis: the importance of controlling for baseline utility

Andrea Manca, Neil Hawkins, Mark Sculpher · Health Economics · 2004 · 1.1K citations

Pharmacy, Biostatistics, Pharmacoeconomics +16

Cost‐effectiveness acceptability curves – facts, fallacies and frequently asked questions

Elisabeth Fenwick, Bernie J. OʼBrien, Andrew Briggs · Health Economics · 2004 · 943 citations

Pharmacy, Economics, Cost-effectiveness Analysis +16